BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 24902858)

  • 1. A systematic review of microRNA expression profiling studies in human gastric cancer.
    Shrestha S; Hsu SD; Huang WY; Huang HY; Chen W; Weng SL; Huang HD
    Cancer Med; 2014 Aug; 3(4):878-88. PubMed ID: 24902858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candidate microRNA biomarkers in human gastric cancer: a systematic review and validation study.
    Wang JL; Hu Y; Kong X; Wang ZH; Chen HY; Xu J; Fang JY
    PLoS One; 2013; 8(9):e73683. PubMed ID: 24040025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues.
    Guan P; Yin Z; Li X; Wu W; Zhou B
    J Exp Clin Cancer Res; 2012 Jun; 31(1):54. PubMed ID: 22672859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of microRNAs as potential biomarkers for diagnosis and prognosis of gastric cancer.
    Ahadi A
    Immunogenetics; 2021 Apr; 73(2):155-161. PubMed ID: 33399935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA analysis of gastric cancer patients from Saudi Arabian population.
    Bibi F; Naseer MI; Alvi SA; Yasir M; Jiman-Fatani AA; Sawan A; Abuzenadah AM; Al-Qahtani MH; Azhar EI
    BMC Genomics; 2016 Oct; 17(Suppl 9):751. PubMed ID: 27766962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs expression profiles as diagnostic biomarkers of gastric cancer: a systematic literature review.
    Stojanovic J; Tognetto A; Tiziano DF; Leoncini E; Posteraro B; Pastorino R; Boccia S
    Biomarkers; 2019 Mar; 24(2):110-119. PubMed ID: 30387681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Deregulated microRNAs and Their Target Genes in Gastric Cancer.
    Juzėnas S; Saltenienė V; Kupcinskas J; Link A; Kiudelis G; Jonaitis L; Jarmalaite S; Kupcinskas L; Malfertheiner P; Skieceviciene J
    PLoS One; 2015; 10(7):e0132327. PubMed ID: 26172537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of NCAPG, KNL1, miR-148a-3p, miR-193b-3p, and miR-1179 may contribute to the progression of gastric cancer.
    Song B; Du J; Song DF; Ren JC; Feng Y
    Biol Res; 2018 Nov; 51(1):44. PubMed ID: 30390708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The analysis of microRNA-34 family expression in human cancer studies comparing cancer tissues with corresponding pericarcinous tissues.
    Wang L; Yu J; Xu J; Zheng C; Li X; Du J
    Gene; 2015 Jan; 554(1):1-8. PubMed ID: 25452192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and indicates tumor invasiveness and poor prognosis.
    Sakamoto N; Naito Y; Oue N; Sentani K; Uraoka N; Oo HZ; Yanagihara K; Aoyagi K; Sasaki H; Yasui W
    Cancer Sci; 2014 Feb; 105(2):236-43. PubMed ID: 24283384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric Juice MicroRNAs as Potential Biomarkers for Screening Gastric Cancer: A Systematic Review.
    Virgilio E; Giarnieri E; Giovagnoli MR; Montagnini M; Proietti A; D'Urso R; Mercantini P; Balducci G; Cavallini M
    Anticancer Res; 2018 Feb; 38(2):613-616. PubMed ID: 29374683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candidate microRNA biomarkers in human colorectal cancer: systematic review profiling studies and experimental validation.
    Ma Y; Zhang P; Yang J; Liu Z; Yang Z; Qin H
    Int J Cancer; 2012 May; 130(9):2077-87. PubMed ID: 21671476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of aberrantly expressed SERPINH1 by antitumor miR-148a-5p inhibits cancer cell aggressiveness in gastric cancer.
    Kawagoe K; Wada M; Idichi T; Okada R; Yamada Y; Moriya S; Okubo K; Matsushita D; Arigami T; Kurahara H; Maemura K; Natsugoe S; Seki N
    J Hum Genet; 2020 Aug; 65(8):647-656. PubMed ID: 32235846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma miR-940 may serve as a novel biomarker for gastric cancer.
    Liu X; Kwong A; Sihoe A; Chu KM
    Tumour Biol; 2016 Mar; 37(3):3589-97. PubMed ID: 26456959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of miRNA and RNA functions as potential biomarkers for gastric cancer.
    Chen S; Zhu J; Yu F; Tian Y; Ma S; Liu X
    Tumour Biol; 2015 Dec; 36(12):9909-18. PubMed ID: 26168960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
    Zhang C; Zhang CD; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candidate miRNAs in human breast cancer biomarkers: a systematic review.
    Adhami M; Haghdoost AA; Sadeghi B; Malekpour Afshar R
    Breast Cancer; 2018 Mar; 25(2):198-205. PubMed ID: 29101635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma.
    Chen Z; Saad R; Jia P; Peng D; Zhu S; Washington MK; Zhao Z; Xu Z; El-Rifai W
    Cancer; 2013 Jun; 119(11):1985-93. PubMed ID: 23456798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-31 inhibits tumor invasion and metastasis by targeting RhoA in human gastric cancer.
    Ge F; Wang C; Wang W; Liu W; Wu B
    Oncol Rep; 2017 Aug; 38(2):1133-1139. PubMed ID: 28656284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA hsa-mir-3923 serves as a diagnostic and prognostic biomarker for gastric carcinoma.
    Yang X; Zhang Z; Zhang L; Zhou L
    Sci Rep; 2020 Mar; 10(1):4672. PubMed ID: 32170105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.